Therapeutic Doses of Nonsteroidal Anti-Inflammatory Drugs Inhibit Osteosarcoma MG-63 Osteoblast-Like Cells Maturation, Viability, and Biomineralization Potential

Figure 1

Percentage of expression of different surfaces markers of the osteoblast (MG-63), treated for 24 h with doses of 1 and 10 𝜇M of (a) metamizole, (b) dexketoprofen, (c) ketorolac, and (d) acetylsalicylic acid. *𝑃<0.01; **𝑃=0.001; ^𝜑𝑃=0.003; ^#𝑃=0.005; ^†𝑃=0.006; ^¥𝑃=0.03; ^‡𝑃=0.018.

(a)

(b)

(c)

(d)